Back to Results
First PageMeta Content
Corporate finance / Private equity / Venture capital / Sevin Rosen Funds / GlaxoSmithKline / Institutional investor / Initial public offering / Pharmaceutical industry in India / Financial economics / Finance / Investment


VENTURE REPORTER South San Francisco, California-based Cytokinetics raised $40 million in fifth round funding from Alta Partners, CSFB Private Equity, General American Investors, GlaxoSmithKline, HBM BioVentures, Mayfie
Add to Reading List

Document Date: 2008-03-07 11:41:48

Open Document

File Size: 52,62 KB

Share Result on Facebook

City

San Francisco / /

Company

Mizuho Bank / GlaxoSmithKline / Vulcan Ventures / PRM Ventures / Chiron Corporation / Vulcan Inc. / CSFB / Cytokinetics Inc. / Alta Partners / Millennium Pharmaceuticals / Aries Advisors LLC / Sevin Rosen Funds / /

Currency

USD / /

Event

Funding / Business Partnership / /

IndustryTerm

corporate communications / pharmaceutical / finance / biopharmaceutical discovery / /

Organization

Mayfield Fund / FDA / /

Person

Charles Homcy / James H. Sabry / James Spudich / Robert I.Blum / Grant Heidrich / III / Michael Schmertzler / Steve Dow / William J. Rutter / /

Position

SVP finance and corporate development / CFO / General / REPORTER / /

Product

Series D / /

ProvinceOrState

California / /

SocialTag